Donjeta Bali Alia

Dr. Donjeta Bali Alia is a physician and Professor of Pediatrics specializing in pediatric onco-hematology. She is currently working at the Faculty of Medicine, University of Medicine of Tirana, and at the University Hospital Center “Mother Teresa” in Tirana, Albania. Her work focuses on pediatric onco-hematology, clinical research, medical education, pediatric oncology, pediatric hematology, and child health.

Current Position

• Head of Pediatric Onco-Hematology Service, University Hospital Center “Mother Teresa,” Tirana, October 2024–present
• Professor, Faculty of Medicine, University of Medicine of Tirana, December 2023–present
• Associate Professor of Medicine, Faculty of Medicine, University of Medicine of Tirana, July 2019–present
• Physician, Pediatric Department, Onco-Hematology Service, University Hospital Center “Mother Teresa,” January 1997–present

Professional Experience

• Head of Pediatric Onco-Hematology Service at University Hospital Center “Mother Teresa,” Tirana
• General Director of University Hospital Center “Mother Teresa,” Tirana, May 2025–July 2025
• Professor at the Faculty of Medicine, University of Medicine of Tirana
• Associate Professor of Medicine at the Faculty of Medicine, University of Medicine of Tirana
• Physician at the Pediatric Department, Onco-Hematology Service, University Hospital Center “Mother Teresa”
• Professional experience in medicine, clinical research, and medical education

Research Activity

• Pediatric onco-hematology
• Pediatric oncology
• Pediatric hematology
• Retinoblastoma outcomes and presentation
• Pediatric leukemia and lymphoma
• Pediatric Hodgkin lymphoma and non-Hodgkin lymphoma
• Pediatric rare diseases and genetic disorders
• Pediatric hematologic changes after COVID-19
• Child health, pediatric prevention, and public health
• Pediatric medical education and clinical research

Areas of Specialization

• Pediatric onco-hematology
• Pediatric oncology
• Pediatric hematology
• Pediatric medicine
• Retinoblastoma
• Pediatric leukemia
• Pediatric lymphoma
• Clinical research
• Medical education
• Child health

Academic Impact

• Professor of Pediatrics at the Faculty of Medicine, University of Medicine of Tirana
• Associate Professor of Medicine at the Faculty of Medicine, University of Medicine of Tirana
• Author or co-author of 96 publications
• Contributed to pediatric oncology, pediatric hematology, retinoblastoma research, pediatric lymphoma research, rare disease research, and broader pediatric health research
• Active in clinical research and medical education

Publications

Professor Donjeta Bali Alia has 96 publications.

Impact of Environmental Factors on Pediatric Health: Risks, Vulnerabilities, and Preventive Strategies. The view of the European Pediatric Association, Union of National Pediatric Societies and Associations. 2026.
Breaking the Triple Barrier to Equitable and Inclusive Pediatric Research and Innovation. 2026.
Hematologic laboratory changes during post COVID 19 in children. 2026.
European Project on the Competence in Pediatric Atopic Dermatitis Management in Primary Care: Pilot Study in a Balkan region. 2026.
The Role of “One Health” in Pediatric Well-Being. 2026.
Beyond Social Conditions: The Moral Determinants of Children’s Health. 2026.
The Silent Epidemic: Early Onset Ludopathy in Children and the Invisible Digital Threat. 2026.
Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries. 2025.
Children with Medical Complexity and Their Families: Addressing Social Risks and Advancing Integrated Care Models. 2025.
The European Vaccination Challenge: Stemming the Resurgence of Vaccine-Preventable Diseases. 2025.
Case Report: A rare case of PleuroPneumonia and ALL T-cell in a pediatric patient. 2025.
Unequal Beginnings: Determinants of Child Health Across Europe. 2025.
The emotional responses of a 9-year-old patient diagnosed with desmoplastic medulloblastoma. 2025.
The first thousand days: nourishing the developing brain for a lifetime of mental well-being. Narrative review. 2025.
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. 2025.
Paper vs Screen: The Unresolved Conflict in Children’s and Adolescents’ Learning Processes. 2025.
SHIGA TOXIN-PRODUCING ESCHERICHIA COLI INFECTION AND HEMOLYTIC UREMIC SYNDROME IN CHILDREN: A CASE REPORT. 2025.
Retinoblastoma in Albania: A 25-Year Retrospective Analysis. 2025.
Challenges in diagnosis and treatment of Cushing disease in a 12-year-old boy. 2025.
The Risk from Widespread Micro- and Nano-Plastic Contamination on a Global Scale and the Threat to Children’s Health. 2025.
The “Blue Whale” Sometimes Resurfaces: The Phenomena Underlying Phenomenon of Non-Suicidal Injury and Suicide Incitement among Adolescents. 2025.
Navigating Resistance and Adaptation in Health Care: How Pediatricians Can Balance Transformation and Children’s Needs. 2024.
MULTIPLE INFANTILE HEPATIC HEMANGIOMA AND CORRELATION WITH HYPOTHYROIDISM. 2024.
EXPLORING THE LINK: CELIAC DISEASE AND NON-HODGKIN LYMPHOMA IN PEDIATRIC PATIENTS: A CASE REPORT. 2024.
The Multidimensional Condition of Systemic Cooling Poverty Affecting Children’s Health Worldwide. 2024.
The Importance of Medication Review and Pharmacologic Reconciliation in Pediatrics. 2024.
Results of Turner Syndrome Treatment with Recombinant Human Growth Hormone in Albania. 2024.
The Pressing Issue of Food Safety for Infants and the Role of the Pediatrician. 2024.
The Growing Issue of Missing Children: The Need for a Comprehensive Strategy. 2024.
The Global Issue of Violence Toward Children in the Context of War. 2024.
Pediatric Hodgkin Lymphoma Overview in Albania during the Last Decade. 2024.
The Role of Hepcidin, sTfR, and sTfR/Log Ferritin Index for the Differential Diagnosis of Iron Deficiency Anemia and Anemia of Chronic Disease. 2024.
The Global Issue of Female Genital Mutilation. 2024.
Skeletal Manifestations, Bone Pain, and BMD Changes in Albanian Type 1 Gaucher Patients Treated with Taliglucerase Alfa. 2023.
Challenges Confronted by Orphans of Gender-Based Violence Victims. 2023.
Alarming Increase of Eating Disorders in Children and Adolescents. 2023.
The First Familiar Case of PTEN-Related Disorder Reported in Albania. 2023.
Extensive sclerodermoid signs in a pediatric patient after treatment for malignancy. 2023.
Child Opportunity Index: A Multidimensional Indicator to Measure Neighborhood Conditions Influencing Children’s Health. 2023.
Bullying and Cyberbullying Increasing in Preadolescent Children. 2023.
The impact of the endocrine disruptors on child health. 2023.
Food Safety: The European Union’s Food Safety Initiative and Its Impact on Risks from Microbial and Chemical Hazards in Infant Food Chains. 2023.
Endocrine Disruptors and Child Health: Food Contaminant Monitoring in the European Union. 2023.
Perparimet pioniere ne fushen e semundjeve te rralla: rrugetimi yne. 2023.
Prevention and contrast of child abuse and neglect in the practice of European paediatricians: a multi-national pilot study. 2021.
Beta Thalassemia mutations in Albania and their contribution in patients treatment and follow up. 2021.
Malignancies and molecular cytogenetics. 2021.
Prevention and Contrast of Child Abuse and Neglect in the Practice of European Paediatricians: a Multi-national Pilot Study. 2021.
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries. 2021.
Resection of Fourth Segment of Liver as a Cause of Hepatoblastoma in A 8 MonthOld-Boy. 2021.
Travel Burden and Clinical Presentation of Retinoblastoma: Analysis of 1024 Patients from 43 African Countries and 518 Patients from 40 European Countries. 2020.
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. 2020.
Global Retinoblastoma Presentation and Analysis by National Income Level. 2020.
Menghini Needles are Superior to Tru-Cut Needles for Blind Percutaneous Liver Biopsy in Children. 2020.
P342 Clinical course in children diagnosed with hereditary spherocytosis in Albania. 2019.
OC55 Inhibitors in Albanian children with hemophilia A. 2019.
Assessment of Risk Factors, which Affect the Presence of Inhibitors in Children with Hemophilia A: The Albanian Case-control Study. 2019.
The research gap in chronic paediatric pain: A systematic review of randomised controlled trials. 2018.
The use of array CGH in a cohort of Albanian children with development delay/intellectual disability, congenital anomalies and dysmorphic features. 2017.
Maternal and Child Health Care Services in Albania. 2016.
Epidemiologic Observations about Pediatric NHL in Albania. 2016.
Immunological and cytogenetic findings in children with chromosome instability syndromes. 2015.
Malignancies and immunodeficiencies: Implications for hematologists/oncologists. 2015.
Malignancies and immunodeficiencies. Implication for hematologists/oncologists. 2015.
Split hand/foot malformation associated with 7q21-q22.2 deletion: A case report. 2015.
Non Hodgkin Duodenal Lymphoma in a 5 year old girl. 2015.
Clinical and molecular characterization of a patient with a 2p22.3 to 2q24.1 deletion. 2015.
Importance of chromosome analysis in patients with Fanconi anemia. 2015.
International prognostic scoring system (IPSS) in Albanian patients with myelodysplastic syndromes. 2015.
Infantile systemic hyalinosis: a case report. 2015.
Kaposiform Hemangioendotelioma with Kasabach-Merritt Syndrome Treated With Propranolol and Vincristine. 2015.
PO-0035 Propranolol Administration For Treatment Of Immature Infantile Haemangiomas in Infants; Any Cardiac Effects? 2014.
PS-090 Hereditary Spherocytosis And Red Cell Indices MCHC, MCV, RDW. 2014.
PO-0151 Epidemiological Considerations About Paediatric Sarcomas In Albania. 2014.
Ambisome as first line treatment of a child with ALL associated with the relapse of leishmaniasis. 2014.
Diagnostic and prognostic importance of flow cytometry imunophenotyping in malignant hemopathies in children. 2013.
Cytogenetic characterization in Albanian patients with myelodysplastic syndrome. 2013.
High sensitivity of FISH compared with cytogenetic analysis when tracking patients with chronic myeloid leukemia treated with Gleevec. 2013.
Comparison of fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response in chronic myeloid leukemia patients treated with Gleevec. 2013.
Treatment and follow up of children with chronic hepatitis C in Albania. 2012.
Epidemiology landscape of acute leukemia in children in Albania during the last 30 years. 2010.
Clinical heterogeneity of Fanconi anemia. 2008.
Clinical heterogeneity of Fanconi anemia. Case reports. 2008.
Clinical and genetic heterogeneity in Fanconi anemia. 2006.
Des donnes epidemiollogiques de la leucemie aigue de l’enfant en albanie les 20 dernieres annees. 1999.

All information is sourced from publicly available materials.